Ranbaxy launches generic prasugrel in India
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories, a subsidiary of Daiichi Sankyo, has launched a generic version of the oral antiplatelet agent, prasugrel, in India, as Prasita.